LIVING DOLL
agency: Digitas Health
brand: Arimidex
client: AstraZeneca
photo from left: Rita DiStefano Schuerman, account director • Mike Wilson, director, design technology • Andrew le Blanc, associate creative director • Ilana Grossman, VP, director of marketing
Surviving breast cancer is cause for celebration. And on behalf of the adjuvant breast cancer therapy Arimidex, Digitas Health found a way to let users celebrate life and courage by creating a place online where breast cancer survivors can gather and connect. CelebrationChain.com is the first—and still the only—branded social media site for pharma, says the agency.
Visitors to CelebrationChain.com can create a digital paper doll and send it to a friend to celebrate her life and courage in the face of breast cancer. Different clothing and hairstyle options allow users to customize the doll. All told, it's a poignant way for AstraZeneca to sponsor communication among the close-knit community of breast cancer patients and their advocates.
"AstraZeneca was really forward thinking in challenging us to come up with this," says Ilana Grossman. "All the design elements were grounded in the experience of the customer. These women, they're fighters. They celebrate life. They celebrate their survivorship." In sponsoring this site, Andrew le Blanc described the client as "brave" and "caring," adding, "Here's a company making an investment for a community."
That investment wasn't just emotional, but financial as well. For every doll created, AstraZeneca donates $1 to the nonprofit group Living Beyond Breast Cancer. Since the site's launch in October (Breast Cancer Month), more than 5,500 women have visited the site; they've made over 7,500 virtual dolls for friends and loved ones.
PREVIOUS AGENCY ‹‹ HOME ›› NEXT AGENCY
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
October 23rd 2024Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.